ERBB2 and ovarian carcinoma: We have identified a relatively low amount of HER2 in endometrial cell cultures (Figure 5A, lane 2–9), as compared to the commercial cell line (SK-OV-3) of human ovarian cancer known for abundant expression of this receptor (Figure 5A, lane 1).